1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC
(Synonyms: 1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-Phosphatidylcholine,1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-Phosphocholine,PC(14:0-d7/18:2),14:0-d7/18:2-PC) 目录号 : GC918081-Myristoyl-d7-2-linoleoyl-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1-myristoyl-2-linoleoyl-sn-glycero-3-PC by GC- or LC-MS.
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
1-Myristoyl-d7-2-linoleoyl-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1-myristoyl-2-linoleoyl-sn-glycero-3-PC by GC- or LC-MS. 1-Myristoyl-2-linoleoyl-sn-glycero-3-PC is a phospholipid that contains myristic acid and linoleic acid at the sn-1 and sn-2 positions, respectively. It has been found in human plasma.[1]
References:
[1].Uhl, O., Glaser, C.B., Demmelmair, H., et al.Reversed phase LC/MS/MS method for targeted quantification of glycerophospholipid molecular species in plasmaJ. Chromatogr. B Analyt. Technol. Biomed. Life Sci.879(30)3556-3564(2011).
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.3567 mL | 6.7833 mL | 13.5667 mL |
5 mM | 0.2713 mL | 1.3567 mL | 2.7133 mL |
10 mM | 0.1357 mL | 0.6783 mL | 1.3567 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。